These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25212524)

  • 1. Energy metabolism analysis reveals the mechanism of inhibition of breast cancer cell metastasis by PEG-modified graphene oxide nanosheets.
    Zhou T; Zhang B; Wei P; Du Y; Zhou H; Yu M; Yan L; Zhang W; Nie G; Chen C; Tu Y; Wei T
    Biomaterials; 2014 Dec; 35(37):9833-9843. PubMed ID: 25212524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEG-GO@XN nanocomposite suppresses breast cancer metastasis via inhibition of mitochondrial oxidative phosphorylation and blockade of epithelial-to-mesenchymal transition.
    Zhang J; Yan L; Wei P; Zhou R; Hua C; Xiao M; Tu Y; Gu Z; Wei T
    Eur J Pharmacol; 2021 Mar; 895():173866. PubMed ID: 33454376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The α-tocopherol derivative ESeroS-GS induces cell death and inhibits cell motility of breast cancer cells through the regulation of energy metabolism.
    Zhao L; Zhao X; Zhao K; Wei P; Fang Y; Zhang F; Zhang B; Ogata K; Mori A; Wei T
    Eur J Pharmacol; 2014 Dec; 745():98-107. PubMed ID: 25446928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
    Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
    Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Accelerated Proliferation of Malignant Breast Cancer Cells on Planar Graphene Oxide Films.
    Kenry ; Chaudhuri PK; Loh KP; Lim CT
    ACS Nano; 2016 Mar; 10(3):3424-34. PubMed ID: 26919537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalent functionalization of graphene oxide with biocompatible poly(ethylene glycol) for delivery of paclitaxel.
    Xu Z; Wang S; Li Y; Wang M; Shi P; Huang X
    ACS Appl Mater Interfaces; 2014 Oct; 6(19):17268-76. PubMed ID: 25216036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graphene oxide-wrapped PEGylated liquid crystalline nanoparticles for effective chemo-photothermal therapy of metastatic prostate cancer cells.
    Thapa RK; Youn YS; Jeong JH; Choi HG; Yong CS; Kim JO
    Colloids Surf B Biointerfaces; 2016 Jul; 143():271-277. PubMed ID: 27022866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positively charged graphene oxide nanoparticle: precisely label the plasma membrane of live cell and sensitively monitor extracellular pH in situ.
    Zhu H; Gao L; Jiang X; Liu R; Wei Y; Wang Y; Zhao Y; Chai Z; Gao X
    Chem Commun (Camb); 2014 Apr; 50(28):3695-8. PubMed ID: 24575428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-Penetrating Peptide-Modified Graphene Oxide Nanoparticles Loaded with Rictor siRNA for the Treatment of Triple-Negative Breast Cancer.
    Yang YY; Zhang W; Liu H; Jiang JJ; Wang WJ; Jia ZY
    Drug Des Devel Ther; 2021; 15():4961-4972. PubMed ID: 34916779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid-functionalized graphene oxide nanosheets via plasma etching as a platform to combine NIR anticancer phototherapy and targeted drug delivery.
    Mauro N; Scialabba C; Agnello S; Cavallaro G; Giammona G
    Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110201. PubMed ID: 31761243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity of PEGylated graphene oxide on lymphoma cells.
    Du L; Wu S; Li Y; Zhao X; Ju X; Wang Y
    Biomed Mater Eng; 2014; 24(6):2135-41. PubMed ID: 25226911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted delivery and controlled release of doxorubicin into cancer cells using a multifunctional graphene oxide.
    Lv Y; Tao L; Annie Bligh SW; Yang H; Pan Q; Zhu L
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():652-660. PubMed ID: 26652419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyethylene Glycol-Coated Graphene Oxide Loaded with Erlotinib as an Effective Therapeutic Agent for Treating Nasopharyngeal Cancer Cells.
    Lan MY; Hsu YB; Lan MC; Chen JP; Lu YJ
    Int J Nanomedicine; 2020; 15():7569-7582. PubMed ID: 33116488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GO-PEG as a drug nanocarrier and its antiproliferative effect on human cervical cancer cell line.
    Bikhof Torbati M; Ebrahimian M; Yousefi M; Shaabanzadeh M
    Artif Cells Nanomed Biotechnol; 2017 May; 45(3):568-573. PubMed ID: 27027552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide.
    Yang D; Feng L; Dougherty CA; Luker KE; Chen D; Cauble MA; Banaszak Holl MM; Luker GD; Ross BD; Liu Z; Hong H
    Biomaterials; 2016 Oct; 104():361-71. PubMed ID: 27490486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor Effect of GO-PEG-DOX Complex on EMT-6 Mouse Breast Cancer Cells.
    Yan J; Song B; Hu W; Meng Y; Niu F; Han X; Ge Y; Li N
    Cancer Biother Radiopharm; 2018 May; 33(4):125-130. PubMed ID: 29763376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibition of migration and invasion of cancer cells by graphene via the impairment of mitochondrial respiration.
    Zhou H; Zhang B; Zheng J; Yu M; Zhou T; Zhao K; Jia Y; Gao X; Chen C; Wei T
    Biomaterials; 2014 Feb; 35(5):1597-607. PubMed ID: 24290441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-stage inhibition in breast cancer metastasis by orally active triple conjugate, LHTD4 (low molecular weight heparin-taurocholate-tetrameric deoxycholate).
    Alam F; Al-Hilal TA; Park J; Choi JU; Mahmud F; Jeong JH; Kim IS; Kim SY; Hwang SR; Byun Y
    Biomaterials; 2016 Apr; 86():56-67. PubMed ID: 26890038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graphene Oxide Nanosheets Retard Cellular Migration via Disruption of Actin Cytoskeleton.
    Tian X; Yang Z; Duan G; Wu A; Gu Z; Zhang L; Chen C; Chai Z; Ge C; Zhou R
    Small; 2017 Jan; 13(3):. PubMed ID: 27762498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of the mesenchymal to epithelial transition by demethylation- activated microRNA-200c is involved in the anti-migration/invasion effects of arsenic trioxide on human breast cancer cells.
    Si L; Jiang F; Li Y; Ye X; Mu J; Wang X; Ning S; Hu C; Li Z
    Mol Carcinog; 2015 Sep; 54(9):859-69. PubMed ID: 24729530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.